StevenENissenMD

Preventive Cardiology

Professor of Medicine, Cleveland Cl College of Medicine/Case West Res

Dr. Nissen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
9500 Euclid Ave
Cleveland, OH 44195
Phone+1 800-223-2273

Fax+1 216-445-6855

Dr. Steven Nissen is a cardiologist in Cleveland, OH and is affiliated with Cleveland Clinic. He received his medical degree from University of Michigan Medical School and has been in practice 39 years. He specializes in preventive cardiology and is experienced in general cardiology, lipid disorders, preventive cardiology, hypertension, and coronary artery disease. He has more than 500 publications and over 90,000 citations.

University of Kentucky College of MedicineFellowship, Cardiovascular Disease, 1981 - 1983
University of Michigan Medical SchoolClass of 1978

PubMed

1450 citations
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.
Steven E. Nissen, Stephen J. Nicholls, Ilke Sipahi, Peter Libby, Joel S. Raichlen
JAMA. 2006-04-05
150 citations
Effect of naltrexone-bupropion on major adverse cardiovascular events in overweight and obese patients with cardiovascular risk factors: A randomized clinical trial
Steven E. Nissen, Kathy Wolski, Lisa Prcela, Thomas A. Wadden, John B. Buse
JAMA. 2016-03-08
1203 citations
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann
The New England Journal of Medicine. 2016-07-28

Journal Articles

Coronary Revascularization Strategies
Steven E Nissen, Faisal G Bakaeen, JAMA
Effect of C-reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients with High-Risk Vascular Disease
Steven E Nissen, Jeffrey S Riesmeyer, JAMA Cardiology
Original Investigation Effect of Evolocumab on Coronary Plaque Composition
Steven E Nissen, Ransi Somaratne, Rishi Puri, Christie M Ballantyne, ScienceDirect
Statin Denial: An Internet-Driven Cult with Deadly Consequences
Steven Nissen, MD, Annals of Internal Medicine
Join now to see all

Lectures

ADCY9 Genetic Variants and Cardiovascular Outcomes with Evacetrapib in Patients with High-Risk Vascular Disease
Inova Health System, Mclean, Virginia - 4/26/2013
Debate: The LDL Limbo. How Low Should You Go?
ENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/17/2018

Coronary Revascularization StrategiesJuly 2020
Effect of C-reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients with High-Risk Vascular DiseaseJuly 2020
Effect of C-reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients with High-Risk Vascular DiseaseJuly 2020
Effect of C-reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients with High-Risk Vascular DiseaseJuly 2020
ADCY9 Genetic Variants and Cardiovascular Outcomes with Evacetrapib in Patients with High-Risk Vascular DiseaseJuly 2018
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical TrialsMarch 2017
Join now to see all

Easy Blood Check Might Predict an Individual’s Coronary Heart Illness Threat 30 Years Out, Research FindsAugust 31st, 2024
Bringing Together Science and the Lived Experience at Family Heart Global SummitAugust 21st, 2024
Is Fish Oil Helpful or Harmful for the Heart?June 24th, 2024
Join now to see all